Valuation Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:00:03 2026-09-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 377.69 USD | -0.87% |
|
+0.10% | +24.65% |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 10,035 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | 22.2% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 9,286 | 9,070 | 8,928 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | 17.92% | -2.33% | -1.56% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 45.4x | 44.4x | 44.7x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | - | - | - |
| PEG | - | - | - | -0x | -0x | -0.6x | 19.44x | -63.4x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.91x | 3.81x | 3.78x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 3.61x | 3.45x | 3.36x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 22.9x | 21.2x | 20.6x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 32.2x | 28.1x | 26.7x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 30.2x | 28.7x | 26.9x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 3.31% | 3.48% | 3.71% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,569 | 2,632 | 2,654 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 404.7 | 427.7 | 432.6 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 288.4 | 323.3 | 334.4 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 377.69 | 377.69 | 377.69 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,738 | - | - |
| Announcement Date | 2/10/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 45.4x | 3.61x | 22.95x | -.--% | 10.03B | ||
| 28.61x | 3.96x | 15.3x | 2.55% | 175B | ||
| 18.93x | 3.47x | 12.41x | 3.15% | 114B | ||
| 16.64x | 0.19x | 12.23x | 0.78% | 57.98B | ||
| 35.43x | 3.42x | 11.72x | 2.13% | 50.07B | ||
| 28.77x | 7.1x | 18.35x | 1.39% | 50.13B | ||
| 34.75x | 6.11x | 19.18x | -.--% | 32.71B | ||
| 46x | 1.3x | 12.07x | 0.21% | 30.77B | ||
| 43.81x | 7.69x | 27.57x | 0.24% | 26.44B | ||
| 55.45x | 7.38x | 23.73x | 0.38% | 23.96B | ||
| Average | 35.38x | 4.42x | 17.55x | 1.08% | 57.13B | |
| Weighted average by Cap. | 29.48x | 4.00x | 15.46x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIO Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















